PFG Investments »

Abcellera Biologics shares owned by PFG Investments

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by PFG Investments from 13F filings

Historical chart of PFG Investments investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by PFG Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by PFG Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $75k 17k 4.53

More positions owned by PFG Investments

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Vanguard Bd Index Fds Intermed Term (BIV)
Pimco Dynamic Income SHS (PDI)
Johnson & Johnson (JNJ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Ishares Tr Rus 1000 Grw Etf (IWF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for PFG Investments

Top funds holding Abcellera Biologics

Baillie Gifford & Co
Baker Bros. Advisors
Ing Investment Management
Credit Suisse
OrbiMed Advisors
Arrowpoint Asset Management
BlackRock
Founders Fund VII Management
Lazard Asset Management
Federated Investors
Casdin Capital
Guardian Capital Advisors
Millennium Management
Two Sigma Investments
Citadel Advisors

View all funds holding Abcellera Biologics